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ABSTRACT
Objective: To review the clinical data for people with
diabetes mellitus with reference to their location and
clinical care in a general practice in Australia.
Materials and methods: Patient data were extracted
from a general practice in Western Australia. Iterative
data-cleansing steps were taken. Data were grouped
into Statistical Area level 1 (SA1), designated as the
smallest geographical area associated with the Census
of Population and Housing. The data were analysed to
identify if SA1s with people aged 70 years and older,
and with relatively high glycosylated haemoglobin
(HbA1c) were significantly clustered, and whether this
was associated with their medical consultation rate and
treatment. The analysis included Cluster and Outlier
Analysis using Moran’s I test.
Results: The overall median age of the population was
70 years with more males than females, 53% and
47%, respectively. Older people (>70 years) with
relatively high HbA1c comprised 9.3% of all people
with diabetes in the sample, and were clustered around
two ‘hotspot’ locations. These 111 patients do not
attend the practice more or less often than people with
diabetes living elsewhere in the practice (p=0.098).
There was some evidence that they were more likely to
be recorded as having consulted with regard to other
chronic diseases. The average number of prescribed
medicines over a 13-month time period, per person in
the hotspots, was 4.6 compared with 5.1 in other
locations (p=0.26). Their prescribed therapy was
deemed to be consistent with the management of
people with diabetes in other locations with reference
to the relevant diabetes guidelines.
Conclusions: Older patients with relatively high
HbA1c are clustered in two locations within the
practice area. Their hyperglycaemia and ongoing
cardiovascular risk indicates causes other than
therapeutic inertia. The causes may be related to the
social determinants of health, which are influenced by
geography.
INTRODUCTION
The incidence, prevalence and cost of type 2
diabetes mellitus (T2DM) is increasing,1
which makes diabetes a major cause of mor-
bidity and premature mortality in Australia.2–4
Attempts to improve outcomes for people
diagnosed with diabetes were summarised in
a National Service Improvement Framework
for Diabetes.5
The prevalence of diabetes is highest in
those over 75 years of age.6 Older people are
also more likely to have other comorbid con-
ditions.7 Often, although diabetes represents
the most serious long-term risk to patients,
other symptomatic conditions may dominate
medical management. Therefore, comorbid-
ity and age may be important confounding
variables in the management of diabetes.8
In this study, we aimed to investigate the
proﬁle of people who were noted to have
risk factors for atheromatous vascular disease
in the context of diabetes mellitus. These
risk factors include lipid proﬁle, blood pres-
sure and glucose levels. In particular, the
project focused on the location of such
Strengths and limitations of this study
▪ This study extracted data from a large and estab-
lished Australian general practice in a defined
geographical location.
▪ The practice maintained computerised, search-
able, clinical data dating back 20 years, and the
addresses of the majority of patients with type 2
diabetes mellitus were reliably geocoded.
▪ The multidisciplinary project team had data on
individual patients, including their consultation
history, medical history, medication history and
their laboratory test results, and physiological
measurements.
▪ The conclusions are limited by the quality and
completeness of the data collected by the
practice.
▪ In Australia, patients are able to consult more
than one general practice, and the team could
not collect data from all the practices that the
patients might possibly have consulted.
Jiwa M, et al. BMJ Open 2015;5:e009504. doi:10.1136/bmjopen-2015-009504 1
Open Access Research
group.bmj.com on November 20, 2016 - Published by http://bmjopen.bmj.com/Downloaded from 
people and their interactions with general practice,
including their consultation rate, comorbidities and pre-
scribed medication history.
Therefore, the following research questions have been
identiﬁed:
1. Do older people with continuing risk factors asso-
ciated with diabetes mellitus live in proximity to each
other?
2. Do older people with continuing risk factors asso-
ciated with diabetes mellitus receive inadequate
therapy with reference to national guidelines?
METHODS
Case study
It was conducted in the Peel region of Western Australia.
The region is on the west coast, roughly 75 km south of
the state capital, Perth. The Peel region covers an area of
approximately 5648 km2 with a population of about
112 677 people, of whom around two-thirds live in the city
of Mandurah.8 9 Anonymised point-level geographical
data and relevant clinical information, speciﬁcally asso-
ciated with patients with diabetes, were obtained from the
computer data set of a large general practice clinic in this
location using a customised data extraction tool.
Data collection and preparation
Data were extracted on 13 June 2014, and included all
patients with diabetes, as coded by the general practice.
Only data related to patients coded as having T2DM was
considered for analysis. The practice had computerised
data for all their patients dating back 20 years. This data
set was de-identiﬁed by removing all personalised infor-
mation such as names and phone numbers. A series of
iterative data-cleansing steps were taken, which included
data-type conversions, ﬁeld completion and removal of
duplicates, to ensure consistency for subsequent analysis.
Clinical values were reviewed by clinicians for the exclu-
sion of highly unlikely values. Additional patient-level
observations, such as clinic visits (unique attendance)
and geographical measures, including distance and time
travelled to clinic were calculated. Secondary regional
statistics at Statistical Area Level 1 (SA1) were obtained
from the Australian Bureau of Statistics10 for informa-
tion pertaining to local population demographics, a
subset of which included the Socio-Economic Indexes
for Areas (SEIFA), were used in the analysis phase.
Surveillance of people with diabetes should be per-
formed annually.11 Patients who had attended the prac-
tice within 13 months of the extraction date were
deemed current. A period of 13 months was considered
appropriate to allow for issues of appointment timeli-
ness, patient commitments and return of laboratory
results. Analysis of each clinical parameter was under-
taken to determine if it fell within the predetermined
target range based on the goals for optimum manage-
ment from the ‘General practice management of Type II
diabetes recommendations’.11
Geocoding
Geocoding is the process of enriching a description of a
location, most typically a postal address or place name,
with geographic coordinates from spatial reference data,
such as street addresses or postal codes. Of the 1745
patient records obtained from the general practice, 1654
(94.8%) were identiﬁed as being unique. These unique
patient entries were then geocoded, initially using the
Property Street Address (point-level data set) for Western
Australia, generated by Landgate—Western Australia’s
ofﬁcial registry of survey information.12 This resulted in
1141 (69%) matched (address mapped successfully), 437
(26%) unmatched (addresses that could not be success-
fully mapped) and 76 (5%), which were tied (more than
one address per candidate). To assist the mapping rates
for the unmapped data, the ArcGIS address locator was
used. Just over half (230) of the 437 unmapped addresses
were able to be geocoded using ArcGIS. Of the remain-
ing 207 addresses, 121 were deleted due to incomplete
addresses or addresses that were located outside of
Western Australia, leaving 86 addresses that were manu-
ally assessed. All these 86 were validated using Google
Maps to reassess that the localities were accurate and
re-geocoded with ArcGIS. An improvement was observed
through the point-level geocoding of 36 of the 86, leaving
50 addresses which were geocoded manually. This ﬁnal
mapping exercise resulted in 39 that were geocoded, 7
that could not be matched, and 4 that had to be excluded
as they fell outside the study range. A subsequent review
of the merged geocoded addresses excluded a further 21
addresses which were deemed as outliers, resulting in a
total of 1522 addresses. Patients with geocoded addresses
were further reviewed and another 318 were excluded
because they were residing in nursing homes (to avoid
spatial bias). Individuals diagnosed with T1DM, including
those who were deceased, as well as excluding those
patients whose last clinical visit was more than 13 months
ago, resulted in a ﬁnal data set, which comprised 1183
(71.5%) patients with T2DM with reliably geocoded
addresses. The geocoding of patients with T2DM in this
study is illustrated in ﬁgure 1.
Spatial analysis
Local calculations identiﬁed the extent and location of
clustering and indicated where spatial clustering
occurred. The output provided a representation of the
statistical signiﬁcance of the index values in the z-scores
and p values. Sensitivity analyses were performed insofar
as permutations were run in SpaceStat. The analysis
included the Cluster and Outlier Analysis Anselin Local
Moran’s I test. Speciﬁcally, the output in this study
(which was based on the median clinical values by SA1)
was a layer that demonstrated statistical signiﬁcance at
the 0.05 conﬁdence level areas of clusters that were of
high-high values (HH), low-low values (LL), an outlier
of a low value surrounded by high values (LH) and an
outlier of a high value surrounded by low values (HL).
As we wished to protect the identity of the localities, and
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therefore the patients, we did not present maps,
z-scores, or p values.
Review of the medical data
The data were analysed according to the presence of car-
diovascular risk factors, including hypertension, hyper-
lipidaemia and hyperglycaemia. Two levels of analysis
were carried out.
1. Identiﬁcation of cases where the recorded clinical
parameters were beyond the upper acceptable limit
as deﬁned by the guidelines.11
2. Assessment of each patient’s treatment regimen as
recorded in the notes at the time of data extraction,
to identify opportunities for dosage increases or add-
ition of new drugs to improve clinical parameters.
The 2014–2015 guidelines for the general practice
management of T2DM published jointly by the Royal
Australian College of General Practitioners, together
with Diabetes Australia, recommend that patients with
T2DM undergo annual review, which should include the
measurement of blood pressure (BP), glycosylated
haemoglobin (HbA1c), total cholesterol (TC), low-
density lipid cholesterol (LDL-C), high-density lipid
cholesterol (HDL-C), triglycerides (TG), as well as the
patient’s weight, to allow calculation of body mass index
(BMI).11 Parameters included in this study were HbA1c
(%), BP (mm Hg), TC (mmol/L), LDL-C (mmol/L)
and weight (kg). Data were initially coded for currency.
Parameters measured and recorded within 13 months of
the extraction date were deemed current. Analysis of
each parameter was undertaken to determine if it fell
within the predetermined target range based on the
goals for optimum management from the general prac-
tice management of T2DM recommendations,11 namely:
▸ HbA1c target inclusion range: ≤7.5% (guideline
target for HbA1c: ≤7.0%)
▸ BP target inclusion range: ≤135/85mmHg (guideline
target BP: ≤ 130/80)
▸ TC target inclusion range: <4.0 mmol/L
▸ LDL-C target inclusion range: <2.0 mmol/L.
Australian HbA1c measurements have been reported
to have a margin of error of 0.4%, indicating that an
observed level of 7.0% may be anywhere between 6.6%
and 7.4%.13 Increasing the upper limit of the BP target
by 5 mm Hg in both the systolic and diastolic range
allows for a measurement error margin of <5%.
A clinician and researcher assessed records for all
patients whose parameters fell outside the acceptable
ranges for any of the following: HbA1c, BP, TC and LDL.
Current medication, age and comorbidities were evalu-
ated to determine if their current medication regimen
had scope for improvement. Individuals whose BP was
above guidelines, but who were on three or more antihy-
pertensive agents, were coded separately. Individuals with
an HbA1c ≥7.5 and T2DM, who had been prescribed
insulin as part of their treatment regimen were excluded.
Spatial analysis
A series of analysis procedures were implemented to
identify spatial patterns:
1. Median measures for the clinical variables were calcu-
lated at the SA1 level (eg, HbA1c, BMI, LDL, choles-
terol and blood pressure);
2. Bivariate Moran’s I test was applied14 to identify
where SA1s with relatively older age and poorly con-
trolled T2DM that were spatially clustered;
3. Quantifying missing data for each patient;15
4. Patients who resided within the identiﬁed clusters
were investigated to test whether they had presented
with different comorbidities and or used signiﬁcantly
different numbers of medications in comparison with
the rest of the cohort.
RESULTS
Descriptive results
Of the available clinical measures obtained for the 1183
patients, it was found that only 4 (HbA1c, LDL, TC, sys-
tolic BP) were recorded on a consistent basis (>80% of
patients), suggesting that these measures were either
easier to obtain or that others were measured infre-
quently. The distributions for the consistently recorded
measures are shown in ﬁgure 2A–F including the BMI of
the study population.
Sixty-four per cent were found to have a cholesterol
level higher than 4.0 mmol/L (ﬁgure 2A), while 65% of
Figure 1 Geocoding of patients with type 2 diabetes
mellitus.
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the population had increased levels of LDL above the
recommended value of below 2.0 (ﬁgure 2B).
According to the Royal Australian College of General
Practitioners guidelines,11 individuals with diabetes who
had a systolic BP reading higher than 130 mm Hg have
an increased risk of complications. Fifty-nine per cent of
the population under investigation had elevated systolic
readings (ﬁgure 2C).
The patients in this study area were outside the treat-
ment target ranges on all parameters, with the exception
of HbA1c (see ﬁgure 2D). The HbA1c appeared to indi-
cate good outcomes with 68% meeting the recom-
mended target of ≤7% as shown. Eighty-three per cent of
the T2DM cohort were found to be overweight or obese
(BMI≥25 kg/m2).16 Figure 2E highlights BMI categories
for healthy (18–25 years), overweight (25–30 years), mod-
erately obese (30–40 years) and severely obese (40+ years)
ranges.
The median age of the population was 70 years with a
slightly higher representation of males than females,
53% and 47%, respectively (ﬁgure 2F).
Spatial analysis
The HH clusters were concentrated mostly in two loca-
tions, A and B. An analysis was conducted separately on
each clinical measure (HbA1c, BMI, LDL, cholesterol
and BP) using both ArcGIS and SpaceStat tools. Then,
the Hot Spot Analysis (Getis-Ord Gi*) statistic was per-
formed, and the results were similar to the cluster ana-
lysis to the locations of the statistically signiﬁcant
hotspots. In addition, applying SpaceStat software,
Bivariate Moran’s I test was conducted to identify where
SA1s with relatively older age and high level of HbA1c
have been statistically clustered. One location was identi-
ﬁed to be clustered and this location is one of the two
Figure 2 (A–F) Summary distributions for (A) total cholesterol; (B) low-density lipid (LDL); (C) systolic blood pressure;
(D) glycosylated haemoglobin (HbA1c); (E) body mass index (BMI) and (F) age and gender; used to analyse patients with type 2
diabetes mellitus (T2DM). For plots (A–D) dark grey shading represents patients exceeding the clinical thresholds and who are in the
range of concern, while the light grey shading represents patients who are maintaining healthy measures as specified by the Royal
Australian College of General Practitioners.11 All incomplete records for each clinical parameter were excluded from the analysis.
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HH areas identiﬁed in the previous spatial analysis
procedure.
The following hypotheses were tested:
1. Older people (≥70 years) with higher HbA1c are
clustered in speciﬁc geographical locations relative to
the case study area;
2. Patients living in hotspot locations (a geographic
region deﬁned by those individuals statistically clus-
tered on a selected phenotype17) are likely to have a
higher proportion of ‘missing clinical data’ indicating
less attention to their diabetes;
3. People with T2DM living in the hotspot locations
compared with people living elsewhere in the prac-
tice are likely to attend the practice less often, take
fewer medications, have more chronic illness, and are
less likely to be managed as per the guidelines.
Hypothesis 1
Older people with relatively high HbA1c (≥7.5%) com-
prised 9.3% of all people with T2DM in the sample, and
were clustered around two locations, locations A and
B. Location A is relatively deprived, corresponding with
a low SEIFA Index.18 This was below the Western
Australian average of 1021.86 score. Location A has a
median age of 41 years with 22.1% of residents over the
age of 65 years. The median age of the patients with
T2DM living in this location in our study was 69 years.
Location B, however, was a relatively afﬂuent area with
34% of the population over the age of 65 years and a
median age of 54 years. Patients with T2DM from this
location had a median age of 72 years. To protect the
privacy of patients, these locations are not displayed in a
graph.
Hypothesis 2
A comparison between the percentage of patient
records within the identiﬁed hotspot locations (locations
A and B) with missing clinical data, and those in the
remainder of the practice region with missing data, was
conducted. Table 1 indicates that there were no signiﬁ-
cant differences on any measure between hotspot loca-
tions and the rest of the cohort.
Hypothesis 3
Attendance
Our data suggest that people with T2DM in the hotspot
locations do not attend the practice more or less often
than people with T2DM living elsewhere in the practice
(p=0.1) (ﬁgure 3).
Chronic illness
There were only two chronic conditions that people with
T2DM living in hotspot locations were more likely to
have consulted their doctor about, as shown in table 2.
Use of medications
In the hotspot locations, there was an average 4.6 scripts
(number of prescribed medicines as recorded on the
patient records) per person over the 13-month study
Table 1 Missing clinical measurement summary for all T2DM (1183) within the 13-month study period from May 2013 to
June 2014 (p<0.05 is significant)
Clinical measure
Missing measurements
Hotspot locations (n=111) Rest of cohort (n=1072)
p ValueCount Count
HbA1c 5 (4.5) 84 (7.8) 0.21
Cholesterol 6 (5.4) 85 (7.9) 0.34
LDL 12 (10.8) 171 (16.0) 0.15
Systolic 0 (0) 18 (1.7) 0.17
Diastolic 0 (0) 18 (1.7) 0.17
HDL 10 (9.0) 142 (13.2) 0.20
Height 8 (7.2) 97 (9.0) 0.52
Weight 2 (1.8) 65 (6.1) 0.06
Waist circumference 64 (57.7) 655 (61.1) 0.48
Triglycerides 7 (6.3) 96 (9.0) 0.35
HbA1c, glycosylated haemoglobin; HDL, high-density lipid; LDL, low-density lipid; T2DM, type 2 diabetes mellitus.
Figure 3 A box plot comparison of the number of unique
doctor visits between the hotspot locations with the rest of the
practice population.
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period, compared with 5.1 in other locations (p=0.26),
indicating no signiﬁcant difference.
Control of diabetes
The clinical parameters that were appropriately
managed were compared in the hotspot location and
the rest of the cohort. As shown in table 3 all clinical
parameters other than triglycerides were considered
equally well managed in all locations. In some cases
even though the most recent test results were not within
the target range the prescription record for the patient
suggested no scope for improving the prescribed
treatment.
DISCUSSION
The key ﬁnding of this study was that a signiﬁcant pro-
portion of people with a relatively high HbA1c served by
one general practice were clustered in and around two
speciﬁc locations. These patients were managed similarly
with reference to the guidelines. Likewise, attendance
rate at the practice was equivalent to that of other
patients with T2DM served by the practice. There was
not a greater proportion of missing patient data in these
hotspot locations, suggesting that there was neither
greater nor lesser surveillance of these patients. The
locations identiﬁed were, in one case, associated with
socioeconomic deprivation, and in the other a high pro-
portion of older residents. Patients in these locations
were not prescribed more medications, but had a higher
prevalence of some comorbidities.
Three possible explanations exist for the above ﬁnd-
ings. The ﬁrst is that, as has been reported previously,
other comorbidity or psychosocial factors associated with
age distract from the focus on diabetes in the doctor–
patient consultation.7 In the same vein, patients may be
prescribed medicines and given advice, but that does
not mean they are following that advice. Second, these
patients might be attending other practices for advice
about their diabetes. In regard to the ﬁrst possibility, we
did ﬁnd some evidence of greater comorbidity in this
group of patients. With reference to the latter possibility,
national data from Australia suggests that more than
90% of older people will attend only one general prac-
tice.19 This is therefore much less likely. Third, it is also
possible that we are observing that people with similar
Table 2 Percentage of major conditions identified in both hotspot cluster regions compared with the surrounding/other
regions
Chronic condition Hotspot location (n=111 (%)) Rest of cohort (n=1072 (%)) p Value
Angina 5 (4.5) 29 (2.7) 0.56
Asthma 24 (21.6) 155 (14.5) 0.39
Atrial fibrillation 9 (8.1) 99 (9.2) 0.27
Back pain 26 (23.4) 133 (12.4) 0.04*
Cancer 10 (9.0) 120 (11.2) 0.14
Cerebrovascular disease 6 (5.4) 57 (5.3) 0.61
Chronic pain 2 (1.8) 21 (2.0) 0.67
Dementia 2 (1.8) 17 (1.6) 0.89
Depression 25 (22.5) 188 (17.5) 0.92
Gastroesophageal reflux disease 10 (9.0) 143 (13.3) 0.04*
Ischaemic heart disease 9 (8.1) 79 (7.4) 0.69
Myocardial infarction 3 (2.7) 57 (5.3) 0.10
Osteoarthritis 34 (30.6) 270 (25.2) 0.82
*p Value with a significance of ≤0.05.
Table 3 Clinical measures managed per guidelines between the identified hotspot locations and the surrounding areas
Clinical measure
Within guidelines
Hotspot location Rest of the sample
n=111 Count (%) n=1072 Count (%) p Value
HbA1c 67 (60.4) 561 (52.3) 0.11
Cholesterol 30 (27.0) 261 (24.3) 0.53
LDL 27 (24.3) 225 (21.9) 0.41
Systolic 49 (44.1) 463 (45.1) 0.85
Diastolic 65 (58.6) 644 (62.7) 0.76
HDL 54 (48.6) 453 (44.1) 0.70
Triglycerides 28 (25.2) 416 (40.5) 0.005*
BMI 19 (17.1) 163 (15.9) 0.60
*p Value with a significance of ≤0.05.
BMI, body mass index; HbA1c, glycosylated haemoglobin; HDL, high-density lipid; LDL, low-density lipid.
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risk factors, age, social and cultural backgrounds chose
to live in proximity.
If geographical patterns are conﬁrmed in other
Australian practices, this may be evidence of the impact
of geography on outcomes for non-communicable
chronic illness. In a systematic review of the literature
published in 2014, the authors reported that only a few
studies investigated the impact of ‘Neighbourhood and
Built Environment’ on T2DM outcomes.20 Seligman21
reported that people with diabetes who were not able to
afford safe and nutritious food were more likely to have
poor glycaemic control in parts of the USA.21
Additionally, a lower neighbourhood socioeconomic
status was signiﬁcantly associated with poorer physical
and mental health.22 23 Though many authors have sug-
gested that neighbourhood context plays a role in dia-
betes outcomes, this topic needs further research to
fully understand the impact. One important ﬁnding
from our data is that age was a signiﬁcant factor in the
observed geographical patterns. Therefore, elements of
the environment that preclude healthier choices, espe-
cially by older people who may be limited by poor
mobility, may be relevant.24
Finally, we reﬂect on Tudor Hart’s inverse care law.25
Hart posited that people with the greatest need are least
well served. In this study, we present data that suggest that
patients in the hotspot locations were accessing their
general practice as much as patients in other locations,
and yet appear to have poorer results. It is possible that
these patients had greater needs and perhaps should be
attending more often. Alternatively, it is also possible that
the practice is unable to reduce cardiovascular risk related
to diabetes because of other considerations to do with
neighbourhood, built environment and competing prior-
ities for the patient. Therefore, it is not that health services
are less available, but that other health, social or environ-
mental factors may limit the impact of those services.
STRENGTHS AND LIMITATIONS
We acknowledge several limitations of this study. The
project was conducted with data from only one, albeit
large practice in Western Australia. The patterns
observed are likely to be inﬂuenced by the local organ-
isation of the healthcare services. Patients are able to
consult practitioners at multiple practices in this setting
and we were not able to collect data from those prac-
tices. The conclusions are limited by the quality and
completeness of the data collected by the practice.
Despite these limitations, the study offers a new perspec-
tive on the healthcare of patients with diabetes. Thus,
we generate a hypothesis that such patterns may inspire
new geographically driven approaches to the manage-
ment of T2DM.26 27
In addition, we acknowledged the signiﬁcance of
having access to point-level data in this study; this aligns
with the ﬁndings of Bagheri23 that highlighted limita-
tions with only using SA1 (aggregated) data. Access to
point-level data allowed us to add contextual-based evi-
dence, such as medication prescription, GP attendance
and speciﬁc individual clinical parameters, while main-
taining privacy of data.
CONCLUSIONS
Older people with T2DM and higher cardiovascular risk
have been shown to be clustered in deﬁned geographical
locations. If such geographical patterns for chronic dis-
eases such as diabetes are conﬁrmed in other places, the
data offer the prospect of more geographically targeted
interventions to reduce health risks related to diabetes.
We hope that future studies will adopt spatial approaches
to analyse patient records and will lead to further devel-
opment of spatial techniques in analysing patient data.
Studies in this domain are important not only in terms of
their health applications and spatial techniques, but also
for targeting scarce resources by adding a spatial lens.
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